PVI
FPRX

Pura Vida Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Pura Vida Investments’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-75,000
Closed -$3.07M – 107
2017
Q3 		$3.07M Buy
+75,000
New +$2.35M 0.9% 44

Other funds holding FPRX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pura Vida Investments's FPRX Position: Q4 2020 in Review

Pura Vida Investments sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2020, closing a stake of 322,452 shares — an estimated $1.52M sold.

Pura Vida Investments first reported a position in FPRX in Q4 2015 and held it in 8 quarters. The position peaked at $1.52M in Q3 2020. 125 funds tracked by Wall St. Rank hold FPRX as of Q4 2020.

  • Pura Vida Investments reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Pura Vida Investments sold 322,452 Five Prime Therapeutics, Inc. shares in Q4 2020, an estimated $1.52M.
  • Pura Vida Investments first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 8 quarters.
  • Pura Vida Investments's Five Prime Therapeutics, Inc. position peaked at $1.52M in Q3 2020.
  • 125 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2020.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.